Namida

• There are significant gaps in the current breast cancer standard of care, mammography. Additionally, late cancer detection significantly increases treatment costs.
• Half of women do not get annual mammograms.
• Women under 40 are not eligible for a covered mammogram.
• Half of women have dense breast tissue, for whom mammograms are not effective.

Namida has sold over 4,000 cancer screening tests across B2B and B2C markets, totaling over $500,000 in revenue.